The Ipsos Autoimmune Market Sizing Study provides detailed, indication and department-level insights into biologic treatment volumes across rheumatology, dermatology and gastroenterology indications. By understanding evolving prescribing patterns, biosimilar impact, and new mechanism-of-action entry, this study equips stakeholders to assess market share, identify priority indications, and forecast future potential for existing and pipeline biologics with confidence.
Drawing on real-world data consistently collected over a four-year timeframe, this report provides an intricate exploration of the psoriatic arthritis treatment market in Japan. With a specific focus on biologic and targeted synthetic DMARDs, we shine a spotlight on their continued impact in this market, delivering a comprehensive analysis of evolving treatment patterns, prescribing behaviours, and market dynamics.
With the advent of biologic and JAK inhibitor medications for atopic dermatitis within the last decade, this therapeutic landscape has been fundamentally shifting. Trended data analysis from Ipsos’ Atopic Dermatitis Therapy Monitor provides an unparalleled view of the impact of these new entrants across multiple facets, including real-world prescribing habits, patient journey modifications and influences on HCP attitudes and behaviour.
Drawing on real-world data consistently collected over a four-year timeframe, this report provides an intricate exploration of the psoriasis treatment market in Japan. With a specific focus on biologic and novel oral systemic therapies, we shine a spotlight on their continued impact in this market, delivering a comprehensive analysis of evolving treatment patterns, prescribing behaviours, and market dynamics.
Ipsos' Social Intelligence Analytics report delivers novel insights into the authentic patient experience, analysing over 9,000 social media posts and forum discussions across global platforms. The findings highlight critical disconnects in the AD patient journey, enabling companies to develop targeted solutions that address true patient needs, enhance treatment adherence, and strengthen market positioning.